2/IMO the 2 main highlights in Verve’s #JPM25 presentation were its nomination of $VERV-301 as a development candidate targeting the Lpa gene but moreover that it intends to deliver an opt-in package of $VERV-102 to $LLY in 2H with potential decision to be made by year’s end $XBI
#JPM25 #VERV #VERV #LLY #XBI